| Literature DB >> 34092240 |
Mitsuhiro Nakamura1,2, Megumi Nakao3, Keiho Imanishi4, Hideaki Hirashima5, Yusuke Tsuruta6,7.
Abstract
BACKGROUND: We investigated the geometric and dosimetric impact of three-dimensional (3D) generative adversarial network (GAN)-based metal artifact reduction (MAR) algorithms on volumetric-modulated arc therapy (VMAT) and intensity-modulated proton therapy (IMPT) for the head and neck region, based on artifact-free computed tomography (CT) volumes with dental fillings.Entities:
Keywords: 3D GAN; Head and neck cancer; Metal artifact reduction; VMAT and IMPT
Mesh:
Substances:
Year: 2021 PMID: 34092240 PMCID: PMC8182914 DOI: 10.1186/s13014-021-01827-0
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Fig. 1Schemas of dental arch for each case. Teeth painted by light gray are dental fillings in the m4 group, and by both light and dark gray are in m8 groups
Fig. 2Representative axial slices from Reference, Artifacts, Water, and GAN-MAR CT volumes in (upper) m4 and (lower) m8 groups. Difference images to Reference are also shown
Fig. 3Representative (upper) treatment plan and (lower) dose distribution for (left) VMAT and (right) IMPT plan
Summary of RMSE of the HU values and SSIM within the PTV
| RMSE (HU) | SSIM | ||||||
|---|---|---|---|---|---|---|---|
| Artifacts | Water | GAN-MAR | Artifacts | Water | GAN-MAR | ||
| 6.87 (0.84–8.45) | 4.22 (0.84–6.66) | 4.84 (1.33–6.04) | 0.13 | 0.84 (0.75–0.96) | 0.84 (0.76–0.96) | 0.91 (0.80–0.96) | 0.09 |
| 8.69 (1.06–10.64) | 5.95 (1.05–8.46) | 6.24 (1.65–7.34) | < 0.05 | 0.74 (0.66–0.95) | 0.73 (0.65–0.95) | 0.86 (0.73–0.92) | < 0.05 |
Data are shown in median (minimum–maximum)
RMSE root mean square error, SSIM structural similarity, PTV planning target volume
Fig. 4SSIM as a function of the overlap ratio of the artifact corrected volume to the PTV volume for the a m4 and b m8 groups
Fig. 5Axial slices for the case with the worst SSIM in GAN-MAR in the m4 group. The region indicated by the yellow arrow is the part of under-correction. Difference images to Reference are also shown
The difference in DVIs from the reference plan for the PTV
| VMAT | IMPT | |||||
|---|---|---|---|---|---|---|
| D98% (%) | D50% (%) | D2% (%) | D98% (%) | D50% (%) | D2% (%) | |
| Water | 0.2 (− 0.7 to 0.8) | 0.1 (0.0–0.3) | 0.5 (0.0–1.1) | 0.0 (0.0–0.4) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| GAN-MAR | − 0.1 (− 3.0 to 0.1) | − 0.1 (− 0.2 to 0.1) | 0.0 (− 0.2 to 0.0) | 0.0 (− 0.2 to 0.1) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | |
| Water | 0.4 (0.1–0.9) | 0.1 (0.0–0.3) | 0.6 (0.0–1.1) | 0.0 (− 0.3 to 0.4) | 0.0 (0.0–0.0) | 0.0 (− 0.1 to 0.0) |
| GAN-MAR | − 0.4 (− 2.4 to 0.0) | − 0.2 (− 0.5 to 0.1) | − 0.1 (− 0.4 to 0.0) | − 0.3 (− 0.8 to 0.2) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| < 0.05 | 0.29 | 0.70 | < 0.05 | 0.62 | 0.68 | |
Data are shown in median (minimum–maximum)
DVI dose-volumetric index, PTV planning target volume, VMAT volumetric-modulated arc therapy, IMPT intensity-modulated proton therapy, D dose covering xx% of the volume